• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. HERO GRAFT; VASCULAR GRAFT Back to Search Results
Model Number HERO 1002
Device Problems Complete Blockage (1094); Device Operates Differently Than Expected (2913)
Patient Problems Thrombosis (2100); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Event Description
According to the report, over the past three years, the radiologist has had to recanalize the hero graft in 2-3 patients.This report represents the second of three patients.
 
Manufacturer Narrative
According to the report, over the past three years the radiologist has had to recannulize the hero graft in 2-3 patients.This report represents the second of three patients.Although hero 1002 is listed as the product code, both hero 1001 and hero 1002 were investigated.Multiple attempts were made to contact the complainant for additional information; however, all attempts were unsuccessful.Manufacturing records could not be reviewed as lot numbers were not provided.Possible lot numbers could not be determined as dates of implant were unknown.A review was performed of the available information.Two to three patients required "re-cannulized" hero grafts "over the last 3 years." clarification on what was meant by "re-cannulization" was not confirmed.The complaint is most likely describing cases of a hero graft thrombosis/occlusion.Thrombosis is the most common cause of vascular access dysfunction; partial stenosis or full occlusion of prosthesis or vasculature is listed as a potential complication in the hero graft instructions for use (ifu).Hypercoagulability states or inadequately maintained anticoagulation therapy could contribute to an increased risk of thrombosis.Precautions regarding inadequate anticoagulation are provided in the ifu.The following information was not available: patient medical history, implant operative notes, and intervention operative notes.The specific relationship between the hero graft and the cases of patients requiring "re-cannulized" hero grafts cannot be assessed at this time without additional information.The ifu lists the following potential complications with the use of the hero graft: prosthesis failure, and partial stenosis or full occlusion of prosthesis or vasculature.The ifu states "the following patient considerations should be evaluated prior to initiating the implant procedure: the target artery must have an [interior diameter] id of at least 3mm to provide adequate arterial inflow to support the graft." the ifu also states "as with conventional grafts, hero graft may occlude in patients with insufficient anticoagulation or non-compliance with anticoagulation medication.".
 
Event Description
According to the report, over the past three years the radiologist has had to recannulize the hero graft in 2-3 patients.This report represents the second of three patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key5021205
MDR Text Key23707618
Report Number1063481-2015-00173
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K124039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Report Date 07/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/21/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1002
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/24/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-